Advertisement
Advertisement
U.S. markets close in 5 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Todos Medical Ltd. (TOMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0535-0.0014 (-2.55%)
As of 09:53AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0549
Open0.0549
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0530 - 0.0565
52 Week Range0.0160 - 0.6440
Volume758,370
Avg. Volume9,457,590
Market Cap48.92M
Beta (5Y Monthly)-2.12
PE Ratio (TTM)N/A
EPS (TTM)-0.0520
Earnings DateApr 21, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for TOMDF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TODOS MEDICAL LIMITED
    Analyst Report: Zimmer Biomet Holdings IncBased in Warsaw, Indiana, Zimmer Biomet is the nation's largest pure-play maker of orthopedic devices. The company designs, develops and manufactures reconstructive orthopedic implants, including joint, dental and spinal implants; sports injury repair and trauma products; and related orthopedic surgical products. Its primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, distributors, and, in their capacity as agents, healthcare purchasing organizations or buying groups.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement